Clinical Trials
45
Active:0
Completed:39
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:34
Phase 2:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (44 trials with phase data)• Click on a phase to view related trials
Phase 1
34 (77.3%)Phase 3
5 (11.4%)Phase 2
3 (6.8%)Early Phase 1
1 (2.3%)Not Applicable
1 (2.3%)Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT05416021
- Locations
- 🇿🇦
FARMOVS, Bloemfontein, South Africa
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
Phase 1
Completed
- Conditions
- BleedingSafety IssuesPharmacokinetics
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05041699
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸UPMC Magee-Womens Hospital, Center for Family Planning Research, Pittsburgh, Pennsylvania, United States
PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
Phase 1
Completed
- Conditions
- ContraceptionWomenHealthyContraceptive Usage
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT03467347
- Locations
- 🇺🇸
Magee-Women'S Res Inst and Foundation, Pittsburgh, Pennsylvania, United States
A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings
Phase 1
Completed
- Conditions
- HIV-1-infection
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT03234400
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Bridge HIV CRS San Francisco Department of Public Health, San Francisco, California, United States
Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)
- First Posted Date
- 2017-03-09
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Registration Number
- NCT03074786
- Locations
- 🇿🇦
CAPRISA, eThekwini Clinical Research Site, Durban, KwaZulu-Natal, South Africa
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found